Moving forward, there are areas of growth that can supplement tumor vaccines, like the example of ongoing studies utilizing gut microbiota to increase efficacy of anti-PD-1 treatment in advanced melanoma patients [116]. This evidence concerns the gene PDCD1 and melanoma.